Armata Pharmaceuticals (ARMP) Free Cash Flow (2016 - 2018)
Historic Free Cash Flow for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$3.6 million.
- Armata Pharmaceuticals' Free Cash Flow fell 5023.04% to -$3.6 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$11.2 million, marking a year-over-year decrease of 2078.92%. This contributed to the annual value of -$39.4 million for FY2024, which is 2904.06% up from last year.
- According to the latest figures from Q4 2018, Armata Pharmaceuticals' Free Cash Flow is -$3.6 million, which was down 5023.04% from -$2.2 million recorded in Q3 2018.
- Armata Pharmaceuticals' 5-year Free Cash Flow high stood at -$626000.0 for Q3 2017, and its period low was -$3.9 million during Q1 2014.
- For the 5-year period, Armata Pharmaceuticals' Free Cash Flow averaged around -$2.8 million, with its median value being -$2.8 million (2014).
- Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 25031.28% in 2014, then soared by 8018.99% in 2017.
- Quarter analysis of 5 years shows Armata Pharmaceuticals' Free Cash Flow stood at -$3.2 million in 2014, then increased by 26.15% to -$2.4 million in 2015, then soared by 36.16% to -$1.5 million in 2016, then crashed by 57.97% to -$2.4 million in 2017, then plummeted by 50.23% to -$3.6 million in 2018.
- Its Free Cash Flow was -$3.6 million in Q4 2018, compared to -$2.2 million in Q3 2018 and -$1.9 million in Q2 2018.